• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percent of Office of Device Evaluation (ODE) intra- and inter-Office eConsults completed on time during the month

Dictionary: CDRH uses the internal expert consultation process to acquire information and analysis on issues related to medical devices. Intra- and inter-office consultations are completed for a variety of work products requiring expertise within and across CDRH offices, including premarket device submissions, post-approval studies, and compliance and enforcement actions. Inter-office eConsults are used to facilitate the exchange of scientific information and staff expertise across CDRH, critical to making well-supported regulatory decisions. eConsult is the system CDRH uses to manage and monitor expert consult requests.

Information is current as of September 30, 2013

Fiscal Year - 2011

Skip graphic and jump to text data

TimeTargetPercent
Oct 20108583
Nov 20108582
Dec 20108583
Jan 20118580
Feb 20118580
Mar 20118582
Apr 20118586
May 20118582
Jun 20118584
Jul 20118583
Aug 20118583
Sep 20118581

FY 2011 Overall: 83%

Number of ODE intra- and inter-Office eConsults completed on time during the month

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2010N/A565
Nov 2010N/A658
Dec 2010N/A537
Jan 2011N/A594
Feb 2011N/A541
Mar 2011N/A760
Apr 2011N/A657
May 2011N/A687
Jun 2011N/A755
Jul 2011N/A582
Aug 2011N/A712
Sep 2011N/A613

FY 2011 Total: 7,661

Total number of ODE intra- and inter-Office eConsults completed during the month

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2010N/A677
Nov 2010N/A805
Dec 2010N/A647
Jan 2011N/A744
Feb 2011N/A673
Mar 2011N/A928
Apr 2011N/A765
May 2011N/A835
Jun 2011N/A903
Jul 2011N/A699
Aug 2011N/A857
Sep 2011N/A753

FY 2011 Total: 9,286

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.